News|Articles|August 1, 2023

Fluid Pharma and Mikart Partnership: ODT microparticles improve acceptability in patients with Dysphagia

Author(s)Mikart

Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Becoming a Cornerstone of Fujifilm’s CDMO Strategy in Denmark

ByFUJIFILM Biotechnologies

June 5th 2026

Sponsored Content

An Innovative, Modular Approach to Flexible Supply Chain Management

ByFUJIFILM Biotechnologies

June 5th 2026

Sponsored Content

How Integrated Biologics Manufacturing Ecosystem Is Redefining Speed, Scale, and Sustainability

ByFUJIFILM Biotechnologies

June 5th 2026

Sponsored Content

Ensuring the highest purity in injectable formulations with MaxiPure® Polysorbate 80

ByEvonik Health Care

June 3rd 2026

Sponsored Content

Why Lyophilization Projects Fail, and How to Get It Right

ByJubilant HollisterStier

May 28th 2026

Sponsored Content

Fluid Pharma and Mikart Partnership: ODT microparticles improve acceptability in patients with Dysphagia

Related Content

Becoming a Cornerstone of Fujifilm’s CDMO Strategy in Denmark

An Innovative, Modular Approach to Flexible Supply Chain Management

How Integrated Biologics Manufacturing Ecosystem Is Redefining Speed, Scale, and Sustainability

Ensuring the highest purity in injectable formulations with MaxiPure® Polysorbate 80

Why Lyophilization Projects Fail, and How to Get It Right

Trending on Pharmaceutical Technology

PharmTech Weekly Roundup—June 5, 2026

Tom Sellig on CDMO Innovation and US Manufacturing Growth

Generic GLP-1s Enter Canadian Market

Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance

CPHI Americas: How FDA Instability Is Reshaping Pharmaceutical Development